Modified ipilimumab schedule reduces risk of grade 3/4 adverse events Presented ByDr Naveen Vasudev, St James University Hospital, UK TrialPhase 2, PRISM ConferenceESMO 2021 19 November, 2021 09:26
The PRISM project: focusing on biological parameters across neuropsychiatric disorders Presented ByDr Hugh Marston, Eli Lilly and Company Ltd, Germany ConferenceECNP 2020 2 November, 2020 15:56
